The European Commission said it has cleared the proposed acquisition of the German pharmaceutical company Schering AG by Bayer AG also of Germany. The commission said the activities of the parties are mainly complementary with the main overlaps in a few over-the-counter (OTC) and prescription antifungal markets.
Euro2Day
Simplifying Global Compliance
Recommended Products
EU MDR Compliance: A Checklist for Meeting Manufacturing, Safety and Performance Requirements
The FDAnews report EU MDR Compliance can help. Our editors have combed through the regulations, picking out the most minute compliance points and building them into a checklist of 200+ requirements you can use to confirm that you are satisfying all the EU mandates for device manufacturing.
Accelerating Generic Drug Development: The FDA’s New Plan for Increasing Generic Competition
Accelerating Generic Drug Development explains the FDA’s new policy and shows how to navigate the new pathway to approval.
Editor's Picks
Abbott Receives European Approval for Two Pediatric Devices
The devices have already received FDA clearance.
Thirteen States Support Ohio Attorney General’s Bid to Block Bellwether Opioid Trial
“States are in the best position to enter into global settlements and to protect all communities through statewide implementation of policy and ensuring equitable distribution of available funds,” one brief stated.
FDAnews Drug Daily Bulletin
BAYER'S SCHERING BUY UNCONDITIONALLY CLEARED BY EU
May 25, 2006
